These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25192338)

  • 1. How many people living with HIV will be additionally eligible for antiretroviral treatment in Karnataka State, India as per the World Health Organization 2013 guidelines?
    Dodderi SK; Kumar AM; Naik BR; Kanchar A; B B R; Harries AD
    PLoS One; 2014; 9(9):e107136. PubMed ID: 25192338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoption of the 2015 World Health Organization guidelines on antiretroviral therapy: Programmatic implications for India.
    Rewari BB; Agarwal R; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):90-93. PubMed ID: 28597865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Will adoption of the 2010 WHO ART guidelines for HIV-infected TB patients increase the demand for ART services in India?
    Kumar AM; Gupta D; Rewari BB; Bachani D; Mohammed S; Sharma V; Lal K; Reddy HR; Naik B; Prasad R; Yaqoob M; Deepak KG; Shastri S; Satyanarayana S; Harries AD; Chauhan LS; Dewan P
    PLoS One; 2011; 6(9):e24297. PubMed ID: 21931674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?
    Kumar AMV; Singarajipura A; Naik B; Guddemane DK; Patel Y; Shastri S; Kumar S; Deshmukh R; Rewari BB; Harries AD
    J Epidemiol Glob Health; 2017 Mar; 7(1):11-19. PubMed ID: 26821235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling up antiretroviral treatment services in Karnataka, India: impact on CD4 counts of HIV-infected people.
    Shastri S; Boregowda PH; Rewari BB; Tanwar S; Shet A; Kumar AM
    PLoS One; 2013; 8(8):e72188. PubMed ID: 23951294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines.
    Nelson LJ; Beusenberg M; Habiyambere V; Shaffer N; Vitoria MA; Montero RG; Easterbrook PJ; Doherty MC
    AIDS; 2014 Mar; 28 Suppl 2():S217-24. PubMed ID: 24849481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples.
    Gupta S; Granich R; Suthar AB; Smyth C; Baggaley R; Sculier D; Date A; Desai MA; Lule F; Raizes E; Blanc L; Hirnschall G
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e87-97. PubMed ID: 23187942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next generation of the World Health Organization's global antiretroviral guidance.
    Hirnschall G; Harries AD; Easterbrook PJ; Doherty MC; Ball A
    J Int AIDS Soc; 2013 Jun; 16(1):18757. PubMed ID: 23819908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.
    Odhiambo JO; Kellogg TA; Kim AA; Ng'ang'a L; Mukui I; Umuro M; Mohammed I; De Cock KM; Kimanga DO; Schwarcz S;
    J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S116-22. PubMed ID: 24732815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy.
    Harries AD; Ford N; Jahn A; Schouten EJ; Libamba E; Chimbwandira F; Maher D
    BMC Public Health; 2016 Sep; 16(1):938. PubMed ID: 27600800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India.
    Gupte AN; Kadam D; Sangle S; Rewari BB; Salvi S; Chavan A; Nimkar S; Golub J; Gupte N; Gupta A; Marbaniang I; Mave V
    BMC Infect Dis; 2019 Oct; 19(1):914. PubMed ID: 31664933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and its determinants among people living with HIV attending an antiretroviral treatment center in Delhi, India.
    Anuradha S; Makkar AM; Nandi PK; Rajeshwari K
    Indian J Public Health; 2020; 64(2):148-153. PubMed ID: 32584297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of adopting new WHO guidelines for antiretroviral therapy initiation in Ethiopia.
    Konings E; Ambaw Y; Dilley K; Gichangi P; Arega T; Crandall B
    Bull World Health Organ; 2012 Sep; 90(9):659-63. PubMed ID: 22984310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.